CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Boda Boda Taxis In Nakuru: Balancing Tradition With Modernity

On the streets of Nakuru, the abiding bicycle riders are a testament to the city’s culture and economic dynamics.

Despite the rapid modernisation and introduction of motorised transport, these riders continue to thrive, offering an essential service …

Business Community In Kisumu Cry Foul

The business community in Kisumu County has appealed to President William Ruto to lend a listening ear to the grievances of Gen Z so as to ease the current standoff in the country.

The business community said the heavy losses they have incurred follo…